Managing regulatory dossiers requires dealing with vast volumes of data. The need for consistency among documents is at an all-time high. Keeping up with the changing global regulatory environment is another must. Manual workflows in this process can cause delays in submissions and increase error rates. AI dossier automation streamlines the flow of authoring and automates repetitive tasks. It catches inconsistencies early on in the process. This enhances the quality of the submission and enables experts to concentrate on regulatory decisions.
What is Regulatory Dossier Automation?
A regulatory dossier is a collection of documents that prove a pharmaceutical product is of high quality, safe, and effective for regulatory approval.
The manual drafting, review, and repetitive quality control of these dossiers tend to be time-consuming and inconsistent.
Regulatory dossier automation reduces those tasks. It helps to use AI to structure content, create documents, and ensure document quality. It becomes easy to maintain them throughout the dossier lifecycle. This enables regulatory teams to operate more efficiently while still being able to oversee experts.
Traditional Dossier Preparation vs. AI Dossier Automation
Preparation of dossiers has traditionally been a manual process. It involves data entry, review, tracking of versions, and multiple other steps. The processes make it harder to avoid inconsistencies and to submit on time.
AI dossier automation simplifies content generation. It automates document review, detects inconsistencies, monitors document versions, and allows content to reuse. AI streamlines the submission process and reduces manual workload. However, regulatory experts continue to ensure scientific accuracy and approval.
| Traditional Process |
AI-Enabled Process
|
| Manual drafting |
AI-assisted authoring
|
| Repeated data entry | Content reuse |
| Manual reviews |
Automated quality checks
|
| Version comparison |
Intelligent change tracking
|
| Separate documents |
Cross-document consistency
|
Where AI Fits into the Pharma Regulatory Submission Lifecycle
AI helps all stages of the submission life cycle, from the beginning to the end. It can help enhance regulatory efficiency and manage the submission process.
Planning & Strategy: AI in regulatory affairs aids in pinpointing relevant regulations and tracking guideline changes. You can develop more effective submission approaches.
AI-Powered Content Authoring: AI regulatory authoring can help in drafting regulatory content and organizing source documents. You can maintain consistency across different submission modules.
Document Review: AI for regulatory submissions automates QC. It identifies inconsistencies and alerts on missing information before submission.
Collaboration & Version Control: AI monitors document changes, compares versions, and facilitates easy collaboration between cross-functional teams.
Lifecycle Management: AI pharmaceutical documentation allows teams to monitor regulatory changes. They can evaluate their impact and maintain dossiers throughout the product lifecycle.
Also Read: AI For Monitoring Regulatory Updates In Pharmaceuticals & Medical Devices
How AI Automates Pharma Regulatory Dossier Authoring
Embracing modern AI regulatory authoring results in speeding up the process. It also enhances consistency and submission quality, backed by expert review. Here are the main features in the dossier creation process:
Intelligent Document Processing
AI gathers, categorizes, and structures data from several documents. This minimizes human data entry and facilitates quick access to key data. AI generates relevant information from PDFs, scanned documents, emails, etc., ensuring easier preparation of regulatory content.
AI-Powered Content Authoring
AI regulatory authoring creates initial regulatory content based on approved source data. The content is more easily reviewed, refined, and finalized by regulatory experts.
Template-Based Document Generation
Standardized regulatory templates are filled in automatically by AI. This makes it consistent and will minimize repetitive authoring efforts. AI can also complete regulatory forms and compile documents ready for submission to eCTD. It minimizes manual preparation prior to eCTD submission.
Cross-Document Content Reuse
AI regulatory document authoring has been enhanced by the use of approved content that can be reused in various submissions. It also reduces duplication and ensures uniformity in dossiers.
Structured Data to Narrative Generation
Structured clinical, quality, and safety data is transformed into submission-ready narratives by AI. This helps to minimize manual writing and enhance accuracy.
Automated Table, Listing & Figure Generation
AI generates tables, listings, and figures directly from trusted data sources. It helps to save time and avoids formatting mistakes when putting together dossiers.
Multi-Source Data Integration
AI collates data from clinical, quality, regulatory, and document management systems. Teams can access information from a single workflow without having to switch between platforms.
AI-Assisted Literature Review
AI can help to streamline literature searches by identifying relevant scientific publications. It also highlights relevant results for record-keeping for regulators.
AI-Powered Quality Control
AI scans documents and identifies formatting, information, and compliance errors. This enhances the quality of AI for regulatory submissions.
Cross-Module Consistency Checking
AI will scan content within each CTD module and highlight any inconsistencies. This helps maintain a consistent message throughout the submission.
Intelligent Change Impact Assessment
AI recognizes the documents that are impacted by regulatory change or product change. Teams are only able to review the affected areas and not the entire dossier.
Version Control & Traceability
AI records all changes and provides a full audit trail. This enhances traceability and minimizes the chance of working with old documents.
Collaborative Regulatory Authoring
Dossiers can be worked on by cross-functional teams at the same time. Version control and controlled access make departments collaborate easily.
AI-Assisted Review & Approval Workflow
AI assigns documents to the appropriate reviewers and monitors reviews during the review process. This reduces the time to approval and increases transparency.
AI-Powered Submission Readiness Assessment
AI reviews the dossier before submission and notifies any gaps. It also enhances the efficiency of AI submission automation by ensuring teams submit with greater confidence.
Also Read: Regulatory Intelligence In Product Registration
Benefits of AI Regulatory Dossier Automation
AI regulatory dossier automation helps regulatory teams with the following benefits:
Faster Authoring
AI regulatory document authoring streamlines content generation. It automates draft section creation and the organization of source documents. This assists regulatory teams in finishing dossiers more quickly.
Improved Quality
Before submission, AI identifies inconsistencies, missing information, and formatting problems. This enhances the overall quality of the regulatory document.
Better Compliance
AI in regulatory affairs supports teams to keep their documents in line with the current regulatory requirements. Monitoring can also be used for compliance that is ongoing.
Reduced Manual Effort
Automation automates repetitive tasks, like data entry, document formatting, and version comparison. Research and regulatory review can be emphasized more for the teams.
Cross-Document Consistency
AI checks for inconsistencies in multiple documents and CTD modules. This will give a consistent and accurate submission package.
Better Collaboration
AI streamlines document sharing, reviews, and approvals across cross-functional teams. All use the most recent approved version.
Knowledge Reuse
Previously accepted content may be reused in multiple submissions, minimizing duplicate efforts. This also leaves organizational knowledge for future projects.
Reduced Submission Timelines
AI submission automation streamlines the entire submission process by automating tasks like drafting, reviewing, and quality checks. Submitting faster can aid in speeding up product approval.
Lower Operational Costs
Automation saves on manual authoring and document management time. This enables organizations to make the best use of resources and boost productivity.
Improved Regulatory Readiness
Teams are better equipped to meet regulatory requirements with automated quality checks and real-time document tracking. Generative AI regulatory affairs solutions also enable organizations to better meet regulatory needs as they change.
AI Use Cases Across CTD Modules
Each CTD module has its own unique way of benefiting from the use of AI. These can help automate repetitive tasks and enhance the quality and consistency of documents. Some of the most often used applications throughout the regulatory submission process are:
| CTD Module | Typical Documents | AI Capabilities |
| Module 1 | Administrative & regional documents |
Automating templates, assembling documents, and validating metadata
|
| Module 2 | CTD summaries & overviews |
AI drafting, content summarization, and cross-reference validation
|
| Module 3 | Quality (CMC) documentation |
Like the use of content reuse, CMC narrative generation, and data extraction
|
| Module 4 | Nonclinical study reports |
Using a narrative generator, a literature summarizer, and a consistency detector to create narratives from literature
|
| Module 5 | Clinical study reports (CSRs), clinical summaries, TLFs |
The generation of the CSR, data summarisation, TLF generation, and quality review
|
Choosing an AI Regulatory Dossier Automation Platform
Not all AI solutions are designed for regulatory processes. The right platform should streamline authoring processes and provide for compliance, traceability, and expert oversight.
When assessing an AI regulatory document management solution, take into account the following:
- Designed for life sciences: Select an AI writing tool that is tailored for the pharmaceutical regulatory landscape instead of a generic tool.
- Regulatory Intelligence: The platform should allow access to the latest regulations, health authority guidance, and regulatory updates in various markets.
- Expert validation: AI-generated content should be backed by regulatory experts to ensure accuracy and minimize compliance risks.
- Traceability: Ensure that documents can be tracked, audited, and changed to facilitate reviews and inspections.
- Seamless integration: The platform should be compatible with the existing RIM, eCTD, and document management systems to ensure no disruption in workflow.
- Scalability: Must be able to be expanded to accommodate several products, markets, and submission types as regulatory operations expand.
AI + regulatory intelligence platforms offer more value in the long term than authoring platforms. For example, Artixio’s QuriousRI goes beyond tracking worldwide regulatory changes. It also provides expert summarization, risk impact analysis, and personalized alerts.
An ideal AI dossier automation solution is one that minimizes manual tasks. It supports regulatory teams to make quicker, better decisions at each stage of the submission process.
Conclusion
AI dossier automation can facilitate more efficient and effective regulatory submissions. It enhances compliance and streamlines manual tasks, all while reducing the time and resources required. The synergies between AI and trustworthy regulatory knowledge and human judgment are optimal.
If you’re looking to modernize your regulatory operations, Artixio helps life sciences companies simplify regulatory operations . We do it through expert consulting and AI-powered solutions. Your team may need to keep track of regulatory changes around the world, understand their effect, and then make quicker regulatory decisions.
QuriousRI is a smarter approach to AI dossier automation to keep up with such changing requirements. For more info, contact us at info@artixio.com.
FAQs
Can AI generate Module 2 summaries?
Yes. Regulatory experts should review the final content, as AI can be used to provide draft summaries from approved data.
Can AI review regulatory documents?
Yes. AI checks for inconsistencies, formatting, or missing elements before submission.
What are the risks of AI in regulatory affairs?
AI can generate incorrect or outdated information without human oversight. There is still a need for expert review.
How does AI improve submission quality?
Quality checks are automated, consistency is boosted, and submission compliance is identified before it’s too late.
Can AI integrate with Veeva Vault and RIM systems?
Yes. Veeva Vault, RIM, and other regulatory platforms support many AI solutions to streamline workflows and improve efficiency.
What is Agentic AI in regulatory authoring?
Agentic AI can engage in multi-step authoring processes. It includes retrieval, drafting, and assisting during document reviews with minimal human intervention.
Can AI automate responses to health authority queries?
AI can create draft answers based on previous information. However, it is essential that those draft answers are checked by regulatory professionals before submitting to the regulators.
How does AI maintain compliance and traceability?
AI monitors document versions, keeps audit trails, and detects regulatory changes that could impact pre-existing dossiers.
